ADD/ADHD Medication Management 1. For patients who present to Health Services reporting that they have a diagnosis of ADD or ADHD and want to be followed for that by a GSU Health Services provider: a. Certain information is required from the patient’s previous medical records prior to a GSU Health Services provider providing medication management for ADD or ADHD. Refer to the ADD-ADHD Patient Informed Consent to Obtain Information Form. The patient must provide the following: i. Adequate records documenting how the diagnosis was made and when it was made is required as per below: 1. A copy of the formal psychological evaluation performed to confirm the diagnosis; OR, 2. A copy of the Connor scales or other scales that were used by parents and teachers to make the diagnosis; OR, 3. A formal letter, on an official letter head, from the patient’s treating provider stating when the diagnosis was made and that the diagnosis was made based on either Connor scale results or a formal psychological evaluation ii. PLUS, in addition to one of the above, medical records documenting the current treatment plan (i.e., what medication the patient is taking, etc.) and documenting compliance are required. b. Records that only demonstrate the current treatment plan will not be considered sufficient; the records must include either the formal psychological evaluation, Connor Scales, or a formal letter from the current treating provider referring to the Connor Scales or formal psychological evaluation as per above. c. Once the appropriate records are reviewed, it will be up to the clinical discretion of the treating provider and/or provider assistant (PA-C) at Health Services to determine whether or not he/she will assume the patient’s care and write prescriptions for their ADD/ADHD medications. d. In the absence of the required documents above, or if determined as necessary by the treating provider at Health Services, Health Service may require the patient to undergo formal neuropsychiatric evaluation and testing to confirm the diagnosis before writing a prescription. This is at the clinical discretion of the treating provider, and any costs associated with that evaluation will be the responsibility of the patient. 2. GSU Health Services providers adhere to the following ADD/ADHD medication prescribing guidelines: a. Patients are required to read and sign the Patient Contract between GSU Health Services Providers and Patients Who Are Prescribed Long-Term Controlled Substances Therapy for ADD/ADHD before the provider will initiate medical therapy at Health Services for the patient’s ADD/ADHD. b. Unless the patient is home for an extended break, the GSU Health Services provider assuming the patient’s care or his/her designee should be the only provider writing a prescription for the ADD/ADHD medication.

c.

d. e. f.

g.

i. Prior to writing the patient’s prescription for the controlled substance medication, the provider will access the Georgia Prescription Drug Monitoring Program (PDMP) databank to ensure the patient has not received the ADD/ADHD medication in the same timeframe from multiple providers. ii. Persons found to be receiving prescriptions from multiple providers may be subject to discharge from care along with academic and criminal disciplinary action. Patients are given a prescription for only a 30 day supply at a time, with no refills; the only exception to this stipulation is if the patient’s insurance company requires a 3 month supply to be dispensed. The prescription will not be refilled prior to the scheduled due date. The prescription will not be refilled if it is lost, stolen, etc., unless the patient presents a police report to that effect. If a GSU Health Services provider assumes the patient’s care for ADD/ADHD, the patient must attend a face to face visit with that provider or his/her designee, at least once every 90 days specifically for ADD/ADHD follow up. Unannounced urine or serum toxicology non-forensic drug testing may be required at the provider’s discretion in order to assure medication compliance and to determine if the patient may be diverting the medication. i. If the provider suspects diversion, abuse, or drug seeking activity, the patient may be subject to academic and criminal disciplinary action. ii. Refusal to provide a sample for testing will be considered noncompliance and will be grounds for discharge from care and possible academic and criminal disciplinary action.